Reviews and PerspectivesReviews in Basic and Clinical Gastroenterology and HepatologyLiver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Section snippets
Cell(s) of Origin
Parenchymal (hepatocytes and cholangiocytes) and nonparenchymal cells (fibroblasts, stellate cells, Kupffer cells, and endothelial cells) form the basic hepatic structure (Figure 2); the existence of stem cells in adult liver has been heavily debated. Hepatocytes constitute 60% to 80% of the total liver mass. Architecturally, these cells are organized in lobules, which can be further divided in functional regions or zones.16 Liver zonation is particularly relevant for hepatocytes, because it
Immune Response
Regardless of the cell type that becomes transformed to initiate tumorigenesis, the developing tumor also requires a specific microenvironment. This is particularly relevant to liver tumors, 90% of which develop under conditions of chronic inflammation.2 Factors that contribute to tumor formation include changes in the extracellular matrix of the liver, signaling between parenchymal and nonparenchymal cells, and immune dysfunction.75 An altered immune response is an important factor in
Classification of HCC Based on Molecular Features
Characterization of molecular subtypes and/or oncogene addiction loops has generated treatment algorithms for several types of cancer, including breast cancer, and they have improved patient outcomes. High-throughput technologies, including single nucleotide polymorphism arrays, combined with transcriptomic and exome sequencing analyses, have identified molecular subtypes of liver cancer, with distinct oncogene signaling pathways and recurrent mutations.96 Even though molecular classifications
Molecular Subclasses of iCCA
There is no effective treatment for iCCA. Reasons include our poor understanding of its pathogenesis and the lack of studies conducted specifically in patients with iCCA, apart from patients with all biliary tract cancers13, 14; this is important because iCCAs are characterized by a distinct set of mutations.14 iCCAs were only recently recognized as a distinct entity with both its own unique staging system (see the 7th edition of the American Joint Committee on Cancer Staging Manual118) and ad
Molecular Features of Uncommon Tumors
FLC is a rare primary liver cancer with few treatment options that typically affects children and young adults without background liver disease.60 FLC is now considered a unique molecular entity within primary liver malignancies.138 FLC is caused by an approximate 400-kilobase deletion in chromosome 19 that incorporates the first exon of DNAJB1 into all but the first exon of PRKACA.139 This fusion is detected in 70%138 to 100% of FLCs.139 In addition, exome sequencing and RNA sequencing studies
Challenges in Tumor Heterogeneity
Liver tumors have a high degree of molecular heterogeneity, not only among patients with the same types of tumors but also within regions within the same tumor or tissue.147 Expert recommendations and consensus definitions have been established to better address the extent and role of cancer heterogeneity in oncology research.148
From a clinical perspective, molecular heterogeneity should be considered within the concepts of trunk and branch as well as driver and passenger mutations. Trunk
Prognostic Markers in HCC
Molecular biomarkers have many applications in cancer. They can improve clinical decision making by helping to predict a patient’s outcome, select patients most likely to respond to a specific treatment, and avoid treatments not likely to be effective. Unlike other cancers such as breast149 and colorectal150 cancers, HCC has no molecular markers that have been incorporated into clinical management.
As a general rule, clinical practice guidelines include recommendations based on a specified set
Molecular Markers of iCCA
Even fewer biomarkers of iCCA have been developed than for HCC; there are only level C data for the efficacy of a biomarker for this tumor type. iCCA is one of the few solid tumors for which no systemic molecular therapy has been approved by the Food and Drug Administration.13 Surgery is the only potentially curative option, although chemotherapy with gemcitabine plus cisplatin is the standard for patients with advanced-stage iCCA.162 According to the International Liver Cancer Association
Future Directions
In the past decade, there have been tremendous advances in our understanding of the cellular and molecular complexity of liver cancers. Sophisticated functional studies and NGS-based research studies have provided information about the cells that form liver tumors and the proteins and pathways involved in hepatocarcinogenesis. These studies support a model of multiple cells of tumor origin. Most of the studies, using in vivo lineage tracing models, revealed an unexpected plasticity of mature
Acknowledgments
The authors thank Jill Gregory for her contribution in the design work of the figures.
References (176)
- et al.
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Lancet
(2012) - et al.
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Lancet
(2012) - et al.
Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice
Clin Gastroenterol Hepatol
(2015) - et al.
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
J Hepatol
(2016) - et al.
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
J Hepatol
(2016) - et al.
Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis
J Hepatol
(2016) - et al.
Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection
Cancer Lett
(2009) - et al.
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
J Hepatol
(2014) - et al.
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
J Hepatol
(2012) - et al.
Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes
Cell Stem Cell
(2014)
Stem cells and liver regeneration
Gastroenterology
The role of hepatocytes and oval cells in liver regeneration and repopulation
Mech Dev
Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming
Cell Stem Cell
Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice
Gastroenterology
Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers
Hepatology
Adult hepatocytes are generated by self-duplication rather than stem cell differentiation
Cell Stem Cell
Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury
Cell Rep
Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer
Cell
Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation
Gastroenterology
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer
Cell
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types
Gastroenterology
Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice
Gastroenterology
A critical role for notch signaling in the formation of cholangiocellular carcinomas
Cancer Cell
Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling
Cell
p62, upregulated during preneoplasia, induces hepatocellular carcinogenesis by maintaining survival of stressed HCC-initiating cells
Cancer Cell
Role of the microenvironment in the pathogenesis and treatment of hepatocellular carcinoma
Gastroenterology
Hallmarks of cancer: the next generation
Cell
Metabolic activation of intrahepatic CD8+ T cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes
Cancer Cell
Pathogenesis, diagnosis, and management of cholangiocarcinoma
Gastroenterology
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes
Gastroenterology
Genetic profiling of hepatocellular carcinoma using next-generation sequencing
J Hepatol
Genetic landscape and biomarkers of hepatocellular carcinoma
Gastroenterology
IGF2 Is up-regulated by epigenetic mechanisms in hepatocellular carcinomas and is an actionable oncogene product in experimental models
Gastroenterology
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma
Gastroenterology
A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection
Gastroenterology
Hepatocellular carcinoma
Nat Rev Dis Primers
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Nat Rev Clin Oncol
WHO classification of tumours of the digestive system
Global cancer statistics, 2012
CA Cancer J Clin
Effect of HCV clearance with direct-acting antiviral agents on HCC
Nat Rev Gastroenterol Hepatol
Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma
Clin Cancer Res
Cellular homeostasis and repair in the mammalian liver
Annu Rev Physiol
Single cell sequencing reveals low levels of aneuploidy across mammalian tissues
Proc Natl Acad Sci U S A
Progenitor cells in diseased human liver
Semin Liver Dis
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
Nat Med
CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells
Int J Cancer
Liver stem cells and their implication in hepatocellular and cholangiocarcinoma
Oncogene
Combined hepatocellular cholangiocarcinoma: a case report and review of literature
Dig Dis Sci
Hepatic biliary epithelial cells acquire epithelial integrity but lose plasticity to differentiate into hepatocytes in vitro during development
J Cell Sci
Mature hepatocytes exhibit unexpected plasticity by direct dedifferentiation into liver progenitor cells in culture
Hepatology
Cited by (863)
Blocking the E2F transcription factor 1/high-mobility group box 2 pathway enhances the intervention effects of α-santalol on the malignant behaviors of liver cancer cells
2024, International Journal of Biochemistry and Cell BiologyClaudins and hepatocellular carcinoma
2024, Biomedicine and Pharmacotherapy
Conflicts of interest The authors disclose the following: A.V. and J.M.L. are coinventors of a patent: “Compositions, Kits, and methods for identification, assessment, prevention and therapy of hepatic disorders.” D.S. and S.L.F. disclose no conflicts.
Funding Supported by the Andrea Marie Fuquay Memorial Research Fellowship (Cholangiocarcinoma Foundation) (to D.S.), the American Association for the Study of Liver Diseases Foundation Alan Hofmann Clinical and Translational Award (to A.V.), National Institutes of Health grants DKR0156621 and AA 020709 (to S.L.F.), and grants from the US National Cancer Institute (P30CA165979 to J.M.L.), the European Commission Horizon 2020 (HEP-CAR 667273-2 to J.M.L.), the Samuel Waxman Cancer Research Foundation (to J.M.L.), the Grant I+D Program (SAF2013-41027) (to J.M.L.), the Asociación Española Contra el Cáncer (to J.M.L.), and the US Department of Defense (grant number CA150272P3 to A.V., S.L. F. and J.M.L).
Author names in bold designate shared co-first authorship.